Determines viral phenotype and genotype resistance to three classes of commonly prescribed antiretroviral drugs: nucleoside reverse transcriptase inhibitors (NRTI), nonnucleoside reverse transcriptase inhibitors (NNRTI), and protease inhibitors (PI). Viral replication capacity is also included.
Phenotype: polymerase chain reaction (PCR) amplification and viral culture; genotype: polymerase chain reaction (PCR) and DNA sequencing.
Phenosense GT
Plasma EDTA
This procedure should be used for patients with documented HIV-1 infection and viral loads =500 copies/mL.
Question ID | Description | Answers |
---|---|---|
Z2096 | Most Recent Viral Load | |
Z2097 | Viral Load Collected Date |
Specimen Type: Plasma
Container/Tube: Lavender-top (EDTA) or plasma preparation tube (PPT)
Specimen Volume: 3 mL
Collection Instructions: Draw blood in either PPT (pearl top) or lavender-top (EDTA) tubes. Centrifuge specimen within six hours of collection. Remove plasma from cells immediately, and transfer specimen to a screw-capped, plastic vial. Freeze 3 mL of PPT plasma or EDTA plasma immediately, send specimen frozen.
To avoid delays in turnaround time when requesting multiple tests, please submit separate frozen specimens for each test requested.
RECOMMENDED:
1. Patient's most recent viral load.
2. Viral load collection date.
NOTE: 1. Intended for use only for patients with viral loads greater than or equal to 500 copies/mL. For best results, viral loads should be confirmed within 2 weeks prior to submission for testing at Monogram.
2. Patient samples submitted <30 days apart are considered duplicate and will be cancelled.
1 mL
Other | PPT(TM) not centrifuged; quantity not sufficient for analysis; heparinized plasma; nonfrozen specimen; specimen exposed to repeated freeze/thaw cycles; specimen received in "pop-top" or "snap-cap" tube |
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Plasma EDTA | Frozen | 14 days |
Determines viral phenotype and genotype resistance to three classes of commonly prescribed antiretroviral drugs: nucleoside reverse transcriptase inhibitors (NRTI), nonnucleoside reverse transcriptase inhibitors (NNRTI), and protease inhibitors (PI). Viral replication capacity is also included.
A final report will be attached in MayoAccess.
Sunday through Saturday
87900/Infectious agent drug susceptibility phenotype prediction
87901/Infectious agent genotype analysis by nucleic acid; reverse transcriptase and protease
87903/Infectious agent phenotype analysis by nucleic acid with drug resistance tissue culture analysis; first through 10 drugs tested
87904/x12 Each additional drug tested
Test Id | Test Order Name | Order LOINC Value |
---|---|---|
FPGT | Phenosense GT | Not Provided |
Result Id | Test Result Name |
Result LOINC Value
Applies only to results expressed in units of measure originally reported by the performing laboratory. These values do not apply to results that are converted to other units of measure.
|
---|---|---|
Z1043 | Phenosense GT | Not Provided |
Change Type | Effective Date |
---|---|
Test Changes - Method | 2023-02-03 |